An exploratory study of nivolumab (nivo) with or without ipilimumab (ipi) according to the percentage of tumoral CD8 cells in advanced metastatic cancer Meeting Abstract
| Authors: | Tsimberidou, A. M.; Drakaki, A.; Khalil, D.; Kummar, S.; Hodi, F. S.; Oh, D. Y.; Cabanski, C. R.; Tezlaff, M.; LaVallee, T.; Spasic, M.; Nissola, L.; Kitch, L. J.; Bayless, N. L.; Selinsky, C.; Ayran, J. C.; O'Donnell-Tormey, J.; Hubbard-Lucey, V. M.; Dugan, U.; Allison, J. P.; Sharma, P. |
| Abstract Title: | An exploratory study of nivolumab (nivo) with or without ipilimumab (ipi) according to the percentage of tumoral CD8 cells in advanced metastatic cancer |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120601094 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.2573 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2573 -- Source: Wos |
